GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+19.47%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$171M
AUM Growth
+$171M
(+19%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
10.1%
Top 10 Holdings %
Top 10 Hldgs %
35.68%
Holding
96
New
28
Increased
11
Reduced
9
Closed
34
Top Buys
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
$6.31M |
| 2 |
Gilead Sciences
GILD
|
$6.13M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$5.57M |
| 4 |
CPHD
Cepheid Inc
CPHD
|
$5.41M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$5.28M |
Top Sells
| 1 |
Community Health Systems
CYH
|
$5.48M |
| 2 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$4.78M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$4.49M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$4.46M |
| 5 |
HCA Healthcare
HCA
|
$4.23M |
Sector Composition
| 1 | Healthcare | 84.01% |
| 2 | Technology | 2.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$21B
| $9.78M | 4.69% | 86,200 +36,200 | +72% | +$4.11M |
|
2
Adverum Biotechnologies
ADVM
$64.6M
| $6.75M | 3.24% | 125,000 +75,000 | +150% | +$4.05M |
|
|
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
| $6.31M | 3.03% | +235,000 | New | +$6.31M |
|
|
4
Gilead Sciences
GILD
$140B
| $6.13M | 2.94% | +65,000 | New | +$6.13M |
|
5
Puma Biotechnology
PBYI
$254M
| $5.68M | 2.72% | 30,000 +25,000 | +500% | +$4.73M |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.43B
| $5.57M | 2.67% | +325,000 | New | +$5.57M |
|
|
CPHD
7
DELISTED
Cepheid Inc
CPHD
| $5.41M | 2.6% | +100,000 | New | +$5.41M |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.34M | 2.56% | 55,000 +20,000 | +57% | +$1.94M |
|
|
LJPC
9
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $5.28M | 2.53% | +286,053 | New | +$5.28M |
|
10
Assertio
ASRT
$80.4M
| $4.83M | 2.32% | 300,000 +180,000 | +150% | +$2.9M |
|
|
DYAX
11
DELISTED
DYAX CORPORATION
DYAX
| $4.57M | 2.19% | +325,000 | New | +$4.57M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $4.51M | 2.16% | 17,500 +2,500 | +17% | +$644K |
|
|
ZLTQ
13
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $4.47M | 2.14% | 160,000 -15,000 | -9% | -$419K |
|
|
NVRO
14
DELISTED
NEVRO CORP.
NVRO
| $4.45M | 2.13% | +115,000 | New | +$4.45M |
|
15
PTC Therapeutics
PTCT
$3.92B
| $4.4M | 2.11% | 85,000 +35,000 | +70% | +$1.81M |
|
|
PTLA
16
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.25M | 2.04% | 150,000 +35,000 | +30% | +$991K |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $4.24M | 2.04% | 90,000 +40,000 | +80% | +$1.89M |
|
|
INSY
18
DELISTED
Insys Therapeutics, Inc.
INSY
| $4.22M | 2.02% | +100,000 | New | +$4.22M |
|
|
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.87M | 1.86% | 300,000 -125,000 | -29% | -$1.61M |
|
|
AIRM
20
DELISTED
Air Methods Corp
AIRM
| $3.74M | 1.8% | +85,000 | New | +$3.74M |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.62M | 1.74% | +40,000 | New | +$3.62M |
|
|
KITE
22
DELISTED
Kite Pharma, Inc.
KITE
| $3.46M | 1.66% | +60,000 | New | +$3.46M |
|
|
SLXP
23
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.45M | 1.65% | +30,000 | New | +$3.45M |
|
|
AMAG
24
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $3.41M | 1.64% | +80,000 | New | +$3.41M |
|
|
ADXS
25
DELISTED
Advaxis, Inc.
ADXS
| $3.39M | 1.63% | +423,100 | New | +$3.39M |
|